- Home
- BY vs NEO Comparison
BY vs NEO Comparison
Compare BY & NEO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BY
- NEO
- Stock Information
- Founded
- BY 1914
- NEO 2001
- Country
- BY United States
- NEO United States
- Employees
- BY N/A
- NEO N/A
- Industry
- BY Major Banks
- NEO Precision Instruments
- Sector
- BY Finance
- NEO Health Care
- Exchange
- BY Nasdaq
- NEO Nasdaq
- Market Cap
- BY 1.2B
- NEO 1.2B
- IPO Year
- BY 2017
- NEO 1999
- Fundamental
- Price
- BY $27.16
- NEO $10.27
- Analyst Decision
- BY Hold
- NEO Buy
- Analyst Count
- BY 3
- NEO 10
- Target Price
- BY $33.67
- NEO $12.56
- AVG Volume (30 Days)
- BY 178.7K
- NEO 5.0M
- Earning Date
- BY 10-23-2025
- NEO 10-28-2025
- Dividend Yield
- BY 1.50%
- NEO N/A
- EPS Growth
- BY 1.86
- NEO N/A
- EPS
- BY 2.81
- NEO N/A
- Revenue
- BY $400,663,000.00
- NEO $709,162,000.00
- Revenue This Year
- BY $18.69
- NEO $10.74
- Revenue Next Year
- BY $3.10
- NEO $9.85
- P/E Ratio
- BY $9.49
- NEO N/A
- Revenue Growth
- BY 7.23
- NEO 10.10
- 52 Week Low
- BY $22.63
- NEO $4.72
- 52 Week High
- BY $32.89
- NEO $19.12
- Technical
- Relative Strength Index (RSI)
- BY 49.62
- NEO 59.93
- Support Level
- BY $26.43
- NEO $9.42
- Resistance Level
- BY $28.40
- NEO $10.58
- Average True Range (ATR)
- BY 0.62
- NEO 0.56
- MACD
- BY 0.03
- NEO -0.09
- Stochastic Oscillator
- BY 53.82
- NEO 42.69
About BY Byline Bancorp Inc.
Byline Bancorp Inc is the holding company for Byline Bank, a full-service commercial bank serving small-and-medium sized businesses, financial sponsors, and consumers. The company offers a broad range of banking products and services to small and medium sized businesses, commercial real estate and online account opening to consumer and business. Also provide trust and wealth management services to its customers. In addition to traditional commercial banking business, company provide small ticket equipment leasing solutions through Byline Financial Group, a wholly-owned subsidiary of Byline Bank.
About NEO NeoGenomics Inc.
NeoGenomics Inc provides oncology diagnostic testing and consultative services which include technical laboratory services and professional interpretation of laboratory test results by licensed physicians or molecular experts in pathology and oncology. It operates a network of cancer-focused testing laboratories in the United States and the United Kingdom. The company operates in a single segment and derives revenue from clients by providing clinical cancer testing, interpretation, and consultative services, molecular and NGS testing, comprehensive technical and professional services offerings, clinical trials and research, validation laboratory services, and oncology data solutions.